Russian firm seeks to produce COVID-19 drug without patent, Vedomosti reports

Russian firm seeks to produce COVID-19 drug without patent, Vedomosti reports Siberia-based Pharmasyntez previously approached Gilead requesting a voluntary licence to produce and distribute the drug in Russia, the company's director, Vikram Punia, had told Reuters this year. https://ift.tt/eA8V8J